Related Experiment Video
Updated: Jan 20, 2026

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
Published on: April 9, 2019
[Protocol proposal for patients under treatment with new oral anticoagulant drugs undergoing prostate biopsy.]
Antonio Alcántara Montero1, José Polo García2
1Centro de Salud Manuel Encinas. Consultorio de Malpartida de Cáceres. Cáceres. España.
Abstract:
Sr Director:Desde que la FDA (Food and Drug Administration) aprobó el uso de los nuevos fármacos anticoagulantes orales (NACOs) para la fibrilación auricular en octubre de 2010, ha habido un aumento exponencial en la prescripción de estos medicamentos, de forma que gradualmente están reemplazando a los tradicionales antagonistas de la vitamina K (AVK) como un nuevo estándar enanticoagulación oral (1).
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
09:11Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
05:32Povidone Iodine Rectal Preparation at Time of Prostate Needle Biopsy is a Simple and Reproducible Means to Reduce Risk of Procedural Infection
06:04Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate (HoLEP).
05:35Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
06:08A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
